检索结果 - Markus F. Scheerer

  • Showing 1 - 14 results of 14
Refine Results
  1. 1
    Long‐term efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes (the <scp>DEPICT</scp>‐2 study): 52‐week results from a randomized controlled trial

    Long‐term efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes (the <scp>DEPICT</scp>‐2 study): 52‐week results from a randomized controlle... 由 Chantal Mathieu, Gottfried Rudofsky, Moshe Phillip, Eiichi Araki, Marcus Lind, Niki Arya, Fredrik Thorén, Markus F. Scheerer, Nayyar Iqbal, Paresh Dandona

    出版 2020
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  2. 2
    Dapagliflozin effects on haematocrit, red blood cell count and reticulocytes in insulin-treated patients with type 2 diabetes

    Dapagliflozin effects on haematocrit, red blood cell count and reticulocytes in insulin-treated patients with type 2 diabetes 由 Jens Aberle, Markus Menzen, Sebastian Schmid, Christoph Terkamp, Elmar Jaeckel, Katja Rohwedder, Markus F. Scheerer, John Xu, Weifeng Tang, Andreas L. Birkenfeld

    出版 2020
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  3. 3
    Kidney outcomes with finerenone: an analysis from the FIGARO-DKD study

    Kidney outcomes with finerenone: an analysis from the FIGARO-DKD study 由 Luís M. Ruilope, Bertram Pitt, Stefan D. Anker, Peter Rossing, Csaba P. Kövesdy, Roberto Pecoits–Filho, Pablo E. Pérgola, Amer Joseph, Andrea Lage, Nicole Mentenich, Markus F. Scheerer, George L. Bakris

    出版 2022
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  4. 4
    Finerenone in Predominantly Advanced CKD and Type 2 Diabetes With or Without Sodium-Glucose Cotransporter-2 Inhibitor Therapy

    Finerenone in Predominantly Advanced CKD and Type 2 Diabetes With or Without Sodium-Glucose Cotransporter-2 Inhibitor Therapy 由 Peter Rossing, Gerasimos Filippatos, Rajiv Agarwal, Stefan D. Anker, Bertram Pitt, Luís M. Ruilope, Juliana C.N. Chan, Adriaan Kooy, Kieran McCafferty, Guntram Schernthaner, Christoph Wanner, Amer Joseph, Markus F. Scheerer, Charlie Scott, George L. Bakris

    出版 2021
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  5. 5
    Effects of canagliflozin versus finerenone on cardiorenal outcomes: exploratory <i>post hoc</i> analyses from FIDELIO-DKD compared to reported CREDENCE results

    Effects of canagliflozin versus finerenone on cardiorenal outcomes: exploratory <i>post hoc</i> analyses from FIDELIO-DKD compared to reported CREDENCE results 由 Rajiv Agarwal, Stefan D. Anker, Gerasimos Filippatos, Bertram Pitt, Peter Rossing, Luís M. Ruilope, John Boletis, Robert Toto, Guillermo E. Umpierrez, Christoph Wanner, Takashi Wada, Charlie Scott, Amer Joseph, Ike Ogbaa, Luke Roberts, Markus F. Scheerer, George L. Bakris

    出版 2021
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  6. 6
    Machine Learning Approaches Reveal Metabolic Signatures of Incident Chronic Kidney Disease in Individuals With Prediabetes and Type 2 Diabetes

    Machine Learning Approaches Reveal Metabolic Signatures of Incident Chronic Kidney Disease in Individuals With Prediabetes and Type 2 Diabetes 由 Jialing Huang, Cornelia Huth, Marcela Covic, Martina Troll, Jonathan Adam, Sven Zukunft, Cornelia Prehn, Li Wang, Jana Nano, Markus F. Scheerer, Susanne Neschen, Gabi Kastenmüller, Karsten Suhre, Michael Laxy, Freimut Schliess, Christian Gieger, Jerzy Adamski, Martin Hrabé de Angelis, Annette Peters, Rui Wang‐Sattler

    出版 2020
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  7. 7
    Finerenone, chronic obstructive pulmonary disease, and heart failure with mildly reduced or preserved ejection fraction: A prespecified analysis of the <scp>FINEARTS</scp>‐<scp>HF</scp> trial

    Finerenone, chronic obstructive pulmonary disease, and heart failure with mildly reduced or preserved ejection fraction: A prespecified analysis of the <scp>FINEARTS</scp>‐<scp>HF<... 由 Jawad H. Butt, Pardeep S. Jhund, Alasdair Henderson, Brian Claggett, Akshay S. Desai, Carolyn S.P. Lam, Katharina Mueller, Markus F. Scheerer, Prabhakar Viswanathan, Michele Senni, Sanjiv J. Shah, Adriaan A. Voors, Faı̈ez Zannad, Bertram Pitt, Muthiah Vaduganathan, Scott D Solomon, John J.V. McMurray

    出版 2025
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  8. 8
    Rationale and design of a randomised phase III registration trial investigating finerenone in participants with type 1 diabetes and chronic kidney disease: The FINE-ONE trial

    Rationale and design of a randomised phase III registration trial investigating finerenone in participants with type 1 diabetes and chronic kidney disease: The FINE-ONE trial 由 Hiddo J.L. Heerspink, Andreas L. Birkenfeld, David Z.I. Cherney, Helen M. Colhoun, Linong Ji, Chantal Mathieu, Per‐Henrik Groop, Richard E. Pratley, Sylvia E. Rosas, Peter Rossing, Jay S. Skyler, Katherine R. Tuttle, Robert Lawatscheck, Charlie Scott, Robert Edfors, Markus F. Scheerer, Peter Kolkhof, Janet B. McGill

    出版 2023
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  9. 9
    Finerenone and Kidney Outcomes in Patients with Heart Failure: The FINEARTS-HF Trial

    Finerenone and Kidney Outcomes in Patients with Heart Failure: The FINEARTS-HF Trial 由 Finnian R. Mc Causland, Muthiah Vaduganathan, Brian Claggett, Ian J. Kulac, Akshay S. Desai, Pardeep S. Jhund, Alasdair Henderson, Meike Brinker, Robert Perkins, Markus F. Scheerer, Patrick Schloemer, Carolyn S.P. Lam, Michele Senni, Sanjiv J. Shah, Adriaan A. Voors, Faı̈ez Zannad, Bertram Pitt, John J.V. McMurray, Scott D. Solomon

    出版 2024
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  10. 10
    Metformin Effect on Nontargeted Metabolite Profiles in Patients With Type 2 Diabetes and in Multiple Murine Tissues

    Metformin Effect on Nontargeted Metabolite Profiles in Patients With Type 2 Diabetes and in Multiple Murine Tissues 由 Jonathan Adam, Stefan Brandmaier, Jörn Leonhardt, Markus F. Scheerer, Robert P. Mohney, Tao Xu, Jie Bi, Markus Rotter, Martina Troll, Shen Chi, Margit Heier, Christian Herder, Wolfgang Rathmann, Guido Giani, Jerzy Adamski, Thomas Illig, Konstantin Strauch, Yixue Li, Christian Gieger, Annette Peters, Karsten Suhre, Donna P. Ankerst, Thomas Meitinger, Martin Hrabé de Angelis, Michael Roden, Susanne Neschen, Gabi Kastenmüller, Rui Wang‐Sattler

    出版 2016
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  11. 11
    Finerenone, Obesity, and Heart Failure With Mildly Reduced/Preserved Ejection Fraction

    Finerenone, Obesity, and Heart Failure With Mildly Reduced/Preserved Ejection Fraction 由 Jawad H. Butt, Alasdair Henderson, Pardeep S. Jhund, Brian Claggett, Akshay S. Desai, James Lay‐Flurrie, Prabhakar Viswanathan, Andrea Lage, Markus F. Scheerer, Siniša Car, Michele Senni, Sanjiv J. Shah, Adriaan A. Voors, Johann Bauersachs, Cândida Fonseca, Mikhail Kosiborod, Gerard C.M. Linssen, Mark C. Petrie, Morten Schou, Subodh Verma, Faı̈ez Zannad, Bertram Pitt, Muthiah Vaduganathan, Scott D Solomon, John J.V. McMurray

    出版 2024
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  12. 12
    Efficacy and Safety of Finerenone in Heart Failure With Preserved Ejection Fraction

    Efficacy and Safety of Finerenone in Heart Failure With Preserved Ejection Fraction 由 John W. Ostrominski, Jingmei Li, Brian Claggett, Zi Michael Miao, Akshay S. Desai, Pardeep S. Jhund, Alasdair Henderson, Markus F. Scheerer, Katja Rohwedder, Flaviana Amarante, Meike Brinker, James Lay‐Flurrie, Carolyn S.P. Lam, Michele Senni, Sanjiv J. Shah, Adriaan A. Voors, Faiez Zannad, Peter Rossing, Luís M. Ruilope, Stefan D. Anker, Bertram Pitt, Rajiv Agarwal, John J.V. McMurray, Scott D Solomon, Muthiah Vaduganathan

    出版 2025
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  13. 13
    SGLT-2 Inhibitors and Cardiovascular Risk

    SGLT-2 Inhibitors and Cardiovascular Risk 由 Matthew A. Cavender, Anna Norhammar, Kåre I. Birkeland, Marit E. Jørgensen, John Wilding, Kamlesh Khunti, Alex Z. Fu, Johan Bodegård, Betina T. Blak, Eric Wittbrodt, Marcus Thuresson, Peter Fenici, Niklas Hammar, Mikhail Kosiborod, Mikhail Kosiborod, Matthew A. Cavender, Alex Z. Fu, John Wilding, Kamlesh Khunti, Anna Norhammar, Kåre I. Birkeland, Marit E. Jørgensen, Reinhard W. Holl, Niklas Hammar, Peter Fenici, Hungta Chen, Johan Bodegård, Betina T. Blak, Eric Wittbrodt, Markus F. Scheerer, Filip Surmont, Kyle Nahrebne, Hanne Løvdal Gulseth, Bendix Carstensen, Marcus Thuresson, Esther Bollow, Luis A. Garcı́a Rodrı́guez, Lucía Cea Soriano, Oscar Fernándex Cantero, Ellen Thiel, Brian R. Murphy

    出版 2018
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  14. 14
    Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes by Sodium–Glucose Cotransporter 2 Inhibitor Treatment: The FIDELITY Analysis

    Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes by Sodium–Glucose Cotransporter 2 Inhibitor Treatment: The FIDELITY Analysis 由 Peter Rossing, Stefan D. Anker, Gerasimos Filippatos, Bertram Pitt, Luís M. Ruilope, Andreas L. Birkenfeld, Janet B. McGill, Sylvia E. Rosas, Amer Joseph, Martin Gebel, Luke Roberts, Markus F. Scheerer, George L. Bakris, Rajiv Agarwal, Diego Aizenberg, Inés Bartolacci, Diego Besada, Julio Bittar, Mariano Chahin, Alicia Elbert, Elizabeth Gelersztein, Alberto Liberman, Laura Maffei, Federico Pérez Manghi, Hugo Sanabria, Augusto Vallejos, Gloria Viñes, Alfredo Wassermann, Walter P. Abhayaratna, Shamasunder Acharya, Elif I. Ekinci, Darren Lee, Richard J. MacIsaac, Peak Mann Mah, Craig Nelson, David Packham, Alexia Pape, Simon D. Roger, Hugo Stephenson, Michael Suranyi, Gary Wittert, Elizabeth Vale, Peter G. Colman, David Colquhoun, Chris Ellis, Kim Joshua, Eugenia Pedagogos, Paul Regal, Duncan J. Topliss, James Vandeleur, Johan Verjans, Gary Wittert, Katie-Jane Wynne, Martin Clodi, Christoph Ebenbichler, Evelyn Fließer-Görzer, Ursula Hanusch, Michael Krebs, Karl Lhotta, Bernhard Ludvik, Gert Mayer, Peter Neudorfer, Bernhard Paulweber, Rudolf Prager, Wolfgang Preiß, Friedrich C. Prischl, G. Schernthaner, Harald Sourij, Martin Wiesholzer, Heinz Drexel, Rainer Oberbauer, Hans‐Robert Schönherr, Peter Doubel, W. Engelen, Pieter Gillard, Jean‐Michel Hougardy, Jean-Marie Krzesinski, Bart Maes, Marijn M. Speeckaert, Koen Stas, Luc Van Gaal, Hilde Vanbelleghem, Francis Duyck, André Scheen, Daniela Antunes, Roberto Botelho, Cláudia Brito, Luís Henrique Santos Canani, Maria Eugênia Fernandes Canziani, Maria Cerqueira, Rogério de Paula, Freddy G. Eliaschewitz, Carlos Eduardo Poli‐de‐Figueiredo, Adriana Costa e Forti, Miguel Nasser Hissa, Maurilo Leite, Emerson de Lima, Irene L. Noronha, Bruno Paolino, Nathalia Paschoalin

    出版 2022
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:

检索工具: